Laser irradiation device for treating peripheral artery occlusion diseases
By using laser devices of multiple wavelengths, especially large-area irradiation of 660nm red light and 980nm near-infrared light, the problem that a single wavelength laser cannot penetrate deep into the skin is solved, and more significant vascular dilation and ulcer treatment effects are achieved, meeting safety standards.
Patent Information
- Application Number
- CN202421509287.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Priority Date
- 2023-06-29
- Filing Date
- 2024-06-28
- Publication Date
- 2025-08-19
- Estimated Expiration
- 2034-06-28
AI Technical Summary
When existing laser light therapy devices are used to treat peripheral arterial occlusion diseases, a single wavelength of laser cannot penetrate deep into the skin, resulting in insignificant treatment effect and the treatment process takes a long time and is difficult to standardize.
Laser devices of various wavelengths are used, including 660nm red light and 980nm near-infrared light. Through large-area irradiation, they penetrate deep into the subcutaneous tissue, combining staggered luminescence and heat dissipation design to improve the therapeutic effect.
Significantly increase blood flow, promote tissue and vascular hyperplasia, reduce the area of ulcers, improve treatment efficiency, reduce treatment time, and comply with international safety standards.